214 related articles for article (PubMed ID: 23788039)
1. The embryonic transcription factor Brachyury blocks cell cycle progression and mediates tumor resistance to conventional antitumor therapies.
Huang B; Cohen JR; Fernando RI; Hamilton DH; Litzinger MT; Hodge JW; Palena C
Cell Death Dis; 2013 Jun; 4(6):e682. PubMed ID: 23788039
[TBL] [Abstract][Full Text] [Related]
2. The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells.
Fernando RI; Litzinger M; Trono P; Hamilton DH; Schlom J; Palena C
J Clin Invest; 2010 Feb; 120(2):533-44. PubMed ID: 20071775
[TBL] [Abstract][Full Text] [Related]
3. WEE1 inhibition alleviates resistance to immune attack of tumor cells undergoing epithelial-mesenchymal transition.
Hamilton DH; Huang B; Fernando RI; Tsang KY; Palena C
Cancer Res; 2014 May; 74(9):2510-9. PubMed ID: 24626094
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of the T-box transcription factor Brachyury increases sensitivity of adenoid cystic carcinoma cells to chemotherapy and radiation in vitro: implications for a new therapeutic principle.
Kobayashi Y; Sugiura T; Imajyo I; Shimoda M; Ishii K; Akimoto N; Yoshihama N; Mori Y
Int J Oncol; 2014 Apr; 44(4):1107-17. PubMed ID: 24504414
[TBL] [Abstract][Full Text] [Related]
5. Brachyury, a driver of the epithelial-mesenchymal transition, is overexpressed in human lung tumors: an opportunity for novel interventions against lung cancer.
Roselli M; Fernando RI; Guadagni F; Spila A; Alessandroni J; Palmirotta R; Costarelli L; Litzinger M; Hamilton D; Huang B; Tucker J; Tsang KY; Schlom J; Palena C
Clin Cancer Res; 2012 Jul; 18(14):3868-79. PubMed ID: 22611028
[TBL] [Abstract][Full Text] [Related]
6. Infiltrating mast cells increase prostate cancer chemotherapy and radiotherapy resistances via modulation of p38/p53/p21 and ATM signals.
Xie H; Li C; Dang Q; Chang LS; Li L
Oncotarget; 2016 Jan; 7(2):1341-53. PubMed ID: 26625310
[TBL] [Abstract][Full Text] [Related]
7. Regulation of brachyury by fibroblast growth factor receptor 1 in lung cancer.
Hu Y; Feng X; Mintz A; Petty WJ; Hsu W
Oncotarget; 2016 Dec; 7(52):87124-87135. PubMed ID: 27893433
[TBL] [Abstract][Full Text] [Related]
8. The potential role of Brachyury in inducing epithelial-to-mesenchymal transition (EMT) and HIF-1α expression in breast cancer cells.
Shao C; Zhang J; Fu J; Ling F
Biochem Biophys Res Commun; 2015 Nov; 467(4):1083-9. PubMed ID: 26393908
[TBL] [Abstract][Full Text] [Related]
9. Immunological targeting of tumor cells undergoing an epithelial-mesenchymal transition via a recombinant brachyury-yeast vaccine.
Hamilton DH; Litzinger MT; Jales A; Huang B; Fernando RI; Hodge JW; Ardiani A; Apelian D; Schlom J; Palena C
Oncotarget; 2013 Oct; 4(10):1777-90. PubMed ID: 24125763
[TBL] [Abstract][Full Text] [Related]
10. Impact of Brachyury on epithelial-mesenchymal transitions and chemosensitivity in non-small cell lung cancer.
Xu K; Liu B; Liu Y
Mol Med Rep; 2015 Jul; 12(1):995-1001. PubMed ID: 25683840
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of the EMT driver brachyury in breast carcinomas: association with poor prognosis.
Palena C; Roselli M; Litzinger MT; Ferroni P; Costarelli L; Spila A; Cavaliere F; Huang B; Fernando RI; Hamilton DH; Jochems C; Tsang KY; Cheng Q; Lyerly HK; Schlom J; Guadagni F
J Natl Cancer Inst; 2014 May; 106(5):. PubMed ID: 24815864
[TBL] [Abstract][Full Text] [Related]
12. Acquisition of anticancer drug resistance is partially associated with cancer stemness in human colon cancer cells.
El Khoury F; Corcos L; Durand S; Simon B; Le Jossic-Corcos C
Int J Oncol; 2016 Dec; 49(6):2558-2568. PubMed ID: 27748801
[TBL] [Abstract][Full Text] [Related]
13. Cancer vaccines targeting the epithelial-mesenchymal transition: tissue distribution of brachyury and other drivers of the mesenchymal-like phenotype of carcinomas.
Hamilton DH; Litzinger MT; Fernando RI; Huang B; Palena C
Semin Oncol; 2012 Jun; 39(3):358-66. PubMed ID: 22595058
[TBL] [Abstract][Full Text] [Related]
14. An integrated functional genomics approach identifies the regulatory network directed by brachyury (T) in chordoma.
Nelson AC; Pillay N; Henderson S; Presneau N; Tirabosco R; Halai D; Berisha F; Flicek P; Stemple DL; Stern CD; Wardle FC; Flanagan AM
J Pathol; 2012 Nov; 228(3):274-85. PubMed ID: 22847733
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of a cytotoxic T-lymphocyte agonist epitope of brachyury, a transcription factor involved in epithelial to mesenchymal transition and metastasis.
Tucker JA; Jochems C; Boyerinas B; Fallon J; Greiner JW; Palena C; Rodell TC; Schlom J; Tsang KY
Cancer Immunol Immunother; 2014 Dec; 63(12):1307-17. PubMed ID: 25186612
[TBL] [Abstract][Full Text] [Related]
16. Loss of the Cyclin-Dependent Kinase Inhibitor 1 in the Context of Brachyury-Mediated Phenotypic Plasticity Drives Tumor Resistance to Immune Attack.
Hamilton DH; McCampbell KK; Palena C
Front Oncol; 2018; 8():143. PubMed ID: 29774202
[TBL] [Abstract][Full Text] [Related]
17. Expression of epithelial-mesenchymal transition driver brachyury and status of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in predicting treatment responses to neoadjuvant chemotherapy of breast cancer.
Lee KH; Kim EY; Park YL; Do SI; Chae SW; Park CH
Tumour Biol; 2017 Jun; 39(6):1010428317710575. PubMed ID: 28621227
[TBL] [Abstract][Full Text] [Related]
18. The T-box transcription factor Brachyury regulates epithelial-mesenchymal transition in association with cancer stem-like cells in adenoid cystic carcinoma cells.
Shimoda M; Sugiura T; Imajyo I; Ishii K; Chigita S; Seki K; Kobayashi Y; Shirasuna K
BMC Cancer; 2012 Aug; 12():377. PubMed ID: 22931165
[TBL] [Abstract][Full Text] [Related]
19. Understanding Molecular Pathways and Targets of Brachyury in Epithelial-mesenchymal Transition (EMT) in Human Cancers.
Song W; Gobe GC
Curr Cancer Drug Targets; 2016; 16(7):586-93. PubMed ID: 27018266
[TBL] [Abstract][Full Text] [Related]
20. microRNA-323 upregulation promotes prostate cancer growth and docetaxel resistance by repressing p73.
Gao Q; Zheng J
Biomed Pharmacother; 2018 Jan; 97():528-534. PubMed ID: 29091904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
